Skip to main content
. 2020 Aug 15;2(6):100171. doi: 10.1016/j.jhepr.2020.100171

Table 4.

Fully adjusted HR of risk factors for cardiac-specific mortality according to the presence of NAFLD (multiple-imputation analysis).

Covariate Individuals with NAFLD
Individuals without NAFLD
HR (95% CI) p value HR (95% CI) p value
Sarcopenia 3.19 (1.17–8.74) 0.0239 2.37 (0.94–5.99) 0.068
Age (years)
 20–39 Reference Reference
 40–59 0.62 (0.14–2.78) 0.5289 0.39 (0.06–2.52) 0.325
 >60 2.86 (1.22–6.70) 0.0153 2.49 (1.20–5.17) 0.0142
Male 3.32 (1.11–9.91) 0.0312 3.30 (1.61–6.76) 0.0011
Race
 Non-Hispanic White Reference Reference
 Non-Hispanic Black 2.04 (0.86–4.86) 0.1060 0.53 (0.23–1.18) 0.1205
 Hispanic 1.57 (0.53–4.63) 0.4125 0.44 (0.13–1.52) 0.1955
 Other race N/A 0.17 (0.02–1.54) 0.1156
Low income 0.69 (0.26–1.81) 0.45 2.31 (1.33–4.01) 0.0031
College 0.88 (0.36–2.14) 0.7833 0.39 (0.14–1.12) 0.0812
Height (cm) 1.00 (0.96–1.05) 0.8556 0.98 (0.94–1.02) 0.3903
Physical inactivity 1.15 (0.50–2.69) 0.7401 1.29 (0.64–2.58) 0.4784
Active smoker 2.04 (0.94–4.45) 0.0726 0.62 (0.25–1.52) 0.2931
Hypertension 1.44 (0.52–3.96) 0.4821 2.99 (1.29–6.93) 0.0107
Hyperlipidaemia 2.00 (0.59–6.82) 0.2691 1.15 (0.47–2.84) 0.7562
Diabetes 3.06 (1.26–7.42) 0.0133 3.93 (1.83–8.47) 0.0005
History of cancer 4.42 (2.20–8.89) <0.0001 3.18 (1.48–6.84) 0.0031
History of CVD 1.81 (0.77–4.27) 0.1765 1.30 (0.59–2.85) 0.5115
History of kidney disease 3.21 (0.78–13.24) 0.1058 3.65 (1.18–11.34) 0.0249

CVD, cardiovascular disease; HR, hazard ratio; NAFLD, non-alcoholic fatty liver disease.